Resultado de búsqueda
Go from concept to market with precision. Harness our meticulously curated biomedical knowledgebase, designed specifically for pharmaceutical research. Boost machine learning accuracy with verified ground truth data. Access structured, in-depth information & broaden your research. Leverage extensive data features for advanced predictive analytics.
Visit DrugBank.com for detailed drug and target data for your pharmaceutical research. Products. Data Library. Explore detailed drug information packages to support your research & drug discovery. Products. Data access in Snowflake. Increase scalability & security by streamlining data sharing & analysis in the cloud.
DrugBank: a comprehensive resource for in silico drug discovery and exploration. [1] The DrugBank database is a comprehensive, freely accessible, online database containing information on drugs and drug targets created and maintained by the University of Alberta and The Metabolomics Innovation Centre located in Alberta, Canada. [1] As both a ...
27 de abr. de 2021 · Generic Name Nirmatrelvir DrugBank Accession Number DB16691 Background. Nirmatrelvir (PF-07321332) is an orally bioavailable 3C-like protease (3CL PRO) inhibitor that is the subject of clinical trial NCT04756531. 4 3CL PRO is responsible for cleaving polyproteins 1a and 1ab of SARS-CoV-2. 1 Without the activity of the SARS-CoV-2 3CL PRO, nonstructural proteins (including proteases) cannot be ...
Go from concept to market with precision. Harness our meticulously curated biomedical knowledgebase, designed specifically for pharmaceutical research. Boost machine learning accuracy with verified ground truth data. Access structured, in-depth information & broaden your research. Leverage extensive data features for advanced predictive analytics.
The DrugBank API is organized around REST. Our API has predictable, resource-oriented URLs, and uses HTTP response codes to indicate API errors. We use built-in HTTP features, like HTTP authentication and HTTP verbs, which are understood by off-the-shelf HTTP clients. JSON is returned by all API responses, including errors, although our API ...
Generic Name Adalimumab DrugBank Accession Number DB00051 Background. Adalimumab is a subcutaneously administered biological disease modifier for the treatment of rheumatoid arthritis and other chronic debilitating diseases mediated by tumor necrosis factor. 2,3 It was originally launched by Abbvie in the U.S. and approved in 2002 by the FDA. 1 This drug is frequently known as Humira.
